Revenue: The sum of all revenue fields included for a company's operating activities.
Tango Therapeutics, Inc. (TNGX) had Revenue of $3.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$3.18M |
$-38.85M |
|
-- |
|
$3.18M |
|
$44.15M |
|
$-40.97M |
|
$2.15M |
|
$-38.82M |
|
$-38.82M |
|
$-38.85M |
|
$-38.85M |
|
$-38.85M |
|
$-38.85M |
|
$-40.97M |
|
$-41.06M |
|
110.54M |
|
110.54M |
|
$-0.35 |
|
$-0.35 |
|
| Balance Sheet Financials | |
$190.10M |
|
$7.79M |
|
$47.79M |
|
$237.89M |
|
$40.02M |
|
-- |
|
$62.91M |
|
$102.94M |
|
$134.95M |
|
$134.95M |
|
$134.95M |
|
110.87M |
|
| Cash Flow Statement Financials | |
$-78.22M |
|
$47.38M |
|
$0.58M |
|
$72.10M |
|
$41.84M |
|
$-30.26M |
|
$13.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1287.87% |
|
-1287.87% |
|
-- |
|
-1220.31% |
|
-1221.41% |
|
$-78.89M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-28.79% |
|
-28.79% |
|
-16.33% |
|
-28.79% |
|
$1.22 |
|
$-0.71 |
|
$-0.71 |
|